The fundamentals of fetal alcohol spectrum disorder: Evaluation of an awareness‐raising webinar
Alcohol, Clinical and Experimental Research · 2026
DOI: 10.1111/acer.70251 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alcohol, Clinical and Experimental Research, 2026. Verfasst von Stewart McDougall und 5 weiteren Autor:innen. Beteiligte Einrichtung: The Fetal Alcohol Advisory Support and Training Team, Health in Social Science, College of Arts, Humanities, and Social Science, University of Edinbu…. Hauptthemen laut MEDLINE: Fetal Alcohol Spectrum Disorders, Health Knowledge, Attitudes, Practice, Awareness, Attitude of Health Personnel. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scottish Government.
Abstract (Originalsprache)
Background
Health professionals in the UK and internationally often lack knowledge of prenatal alcohol exposure (PAE) and fetal alcohol spectrum disorder (FASD). Raising awareness of PAE and FASD across health and social care sectors is vital to support Scotland's implementation of neurodevelopmental pathways. This study evaluated whether engaging in the Fundamentals of FASD contributed to change in (i) attitudes toward the health advice given to pregnant women, (ii) attitudes toward PAE, (iii) attitudes toward FASD, and (iv) knowledge of FASD. Furthermore, this study examined whether knowledge and attitudinal changes are maintained to 12 months posttraining.
Methods
A total of 1327 attendees attended across 14 workshops. Of these, 1005 completed an initial evaluation questionnaire assessing their attitudes and knowledge toward PAE and FASD (pretraining [“T1”]). Repeated‐measure follow‐up responses were collected immediately after training (“T2”; n = 525); at 3 months (“T3”; n = 128); and at 12 months (“T4”; n = 157).
Results
Linear mixed models revealed trainees demonstrated significant improvement on all measures at posttraining but demonstrated a varied pattern at the T3 and T4 follow‐up. Attitudes toward the health advice about alcohol use in pregnancy and alcohol use in pregnancy generally demonstrated no change between T2 and T4, indicating improvement was sustained from T2 to T4. In contrast, attitudes toward FASD and FASD knowledge were observed to significantly decline from T2 through to T4, albeit remaining higher than the pretraining.
Conclusions
Attending the Fundamentals of FASD was associated with significant improvement in knowledge and attitudes toward PAE and FASD. A decline in FASD knowledge across time, albeit remaining above pretraining scores suggests ongoing or refresher training is required. Provision of training within continuing professional development frameworks may help sustain awareness and encourage healthcare professionals to be better equipped in supporting individuals affected by PAE and/or FASD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The Fetal Alcohol Advisory Support and Training Team, Health in Social Science, College of Arts, Humanities, and Social Science, University of Edinburgh, UK.
- NHS Ayrshire and Arran, UK.
ORCID-Profile: Stewart McDougall
Förderung
- Scottish Government
Zitieren
APA
McDougall, S., Brown, R., Shields, J., Brown, S., Burn, R., & O'Rourke, S. (2026). The fundamentals of fetal alcohol spectrum disorder: Evaluation of an awareness‐raising webinar. Alcohol, Clinical and Experimental Research. https://doi.org/10.1111/acer.70251
Vancouver
McDougall S, Brown R, Shields J, Brown S, Burn R, O'Rourke S. The fundamentals of fetal alcohol spectrum disorder: Evaluation of an awareness‐raising webinar. Alcohol, Clinical and Experimental Research. 2026. doi:10.1111/acer.70251
BibTeX
@article{McDougall2026,
author = {McDougall, Stewart and Brown, Ruth and Shields, Jen and Brown, Sarah and Burn, Rachel and O'Rourke, Suzanne},
title = {The fundamentals of fetal alcohol spectrum disorder: Evaluation of an awareness‐raising webinar},
journal = {Alcohol, Clinical and Experimental Research},
year = {2026},
doi = {10.1111/acer.70251}
}
EUVIMED